Ahmed A Othman

39PUBLICATIONS
37CO-AUTHORS
Metabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Mar 07, 2025
Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic-Associated Fatty Liver Disease.

Islam R Younis, Elijah J Weber, Cara Nelson

|Nov 15, 2024
Exposure-Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple-Negative Breast Cancer.

Abhishek G Sathe, Paul M Diderichsen, Floris Fauchet

|Sep 18, 2024
Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase.

Elijah J Weber, Islam R Younis, Cara Nelson

|Aug 30, 2024
Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese Participants.

Islam R Younis, Cara Nelson, Elijah J Weber

|Aug 22, 2024
Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants.

Anees M Dauki, Nishanthan Rajakumaraswamy, Torsten Trowe

|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

Divya Samineni, Karthik Venkatakrishnan, Ahmed A Othman

Pageof 7

Frequent Collaborators

4 joint publications

Islam R Younis

2 joint publications

Anees M Dauki

2 joint publications

Mohamed-Eslam F Mohamed

2 joint publications

Abhishek G Sathe